ログイン
ランキング
お知らせ
ログイン
文献詳細
文献概要
特集 成人先天性心疾患 エキスパートコンセンサス Ⅱ．成人先天性心疾患特有の問題点に対するアプローチ
Fallot四徴症術後右室流出路治療介入のポイントは？
著者： 佐地真育1 七里守1 矢崎諭2
所属機関： 1公益財団法人日本心臓血圧研究振興会附属榊原記念病院循環器内科 2公益財団法人日本心臓血圧研究振興会附属榊原記念病院小児科
ページ範囲：P.440 - P.450
文献購入ページに移動Point
・右室流出路機能不全に対する介入時期はいまだ明らかでない部分があり，症状，画像診断などで総合的に判断し，右室が非可逆性変化を起こす前に介入する必要がある．
・経カテーテル肺動脈弁置換術は手術の代替となる可能性がある．またその低侵襲性から，手術と組み合わせることで，患者の生活の質を向上できる可能性がある．
・小児循環器医，小児心臓外科医，循環器内科医，コメディカルなどがハートチームを形成し，成人先天性心疾患術後患者を包括的に診療することが重要である．
・右室流出路機能不全に対する介入時期はいまだ明らかでない部分があり，症状，画像診断などで総合的に判断し，右室が非可逆性変化を起こす前に介入する必要がある．
・経カテーテル肺動脈弁置換術は手術の代替となる可能性がある．またその低侵襲性から，手術と組み合わせることで，患者の生活の質を向上できる可能性がある．
・小児循環器医，小児心臓外科医，循環器内科医，コメディカルなどがハートチームを形成し，成人先天性心疾患術後患者を包括的に診療することが重要である．
参考文献
1) Ansari MM, Cardoso R, Garcia D, et al:Percutaneous Pulmonary Valve Implantation:Present Status and Evolving Future. J Am Coll Cardiol 66:2246-2255, 2015
2) Benson L:One-Year Outcomes from the Early Feasibility Study of the Harmony Trans-Catheter Pulmonary Valve. Presented at TCT 2016 Nov 01, 2016
3) Hirata Y, Hirahara N, Murakami A, et al:Current status of cardiovascular surgery in Japan, 2015 and 2016:a report based on the Japan Cardiovascular Surgery Database. 1-congenital heart surgery. Gen Thorac Cardiovasc Surg 67:731-735, 2019
4) Geva T:Repaired tetralogy of Fallot:the roles of cardiovascular magnetic resonance in evaluating pathophysiology and for pulmonary valve replacement decision support. J Cardiovasc Magn Reson 13:9, 2011
5) Hickey EJ, Veldtman G, Bradley TJ, et al:Late risk of outcomes for adults with repaired tetralogy of Fallot from an inception cohort spanning four decades. Eur J Cardiothorac Surg 35:156-164;discussion 164, 2009
6) Murphy JG, Gersh BJ, Mair DD, et al:Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot. N Engl J Med 329:593-599, 1993
7) Khanna AD, Hill KD, Pasquali SK, et al:Benchmark Outcomes for Pulmonary Valve Replacement Using The Society of Thoracic Surgeons Databases. Ann Thorac Surg 100:138-145;discussion 145-146, 2015
8) Tweddell JS, Pelech AN, Frommelt PC, et al:Factors affecting longevity of homograft valves used in right ventricular outflow tract reconstruction for congenital heart disease. Circulation. 10219 Suppl 3:III130-135, 2000
9) Giamberti A, Chessa M, Abella R, et al:Morbidity and mortality risk factors in adults with congenital heart disease undergoing cardiac reoperations. Ann Thorac Surg 884:1284-1289, 2009
10) Tretter JT, Friedberg MK, Wald RM, et al:Defining and refining indications for transcatheter pulmonary valve replacement in patients with repaired tetralogy of Fallot:Contributions from anatomical and functional imaging. Int J Cardiol 221:916-925, 2016
11) Dore A, Glancy DL, Stone S, et al:Am J Cardiol 80:906-913, 1997
12) Somerville J:Grown-up congenital heart disease--medical demands look back, look forward 2000. Thorac Cardiovasc Surg 49:21-26, 2001
13) van der Bom T, Zomer AC, Zwinderman AH, et al:The changing epidemiology of congenital heart disease. Nat Rev Cardiol 8:50-60, 2011
14) Oosterhof T, van Straten A, Vliegen HW, et al:Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of Fallot using cardiovascular magnetic resonance. Circulation 1165:545-551, 2000
15) Baumgartner H, Bonhoeffer P, De Groot NM, et al:ESC Guidelines for the management of grown-up congenital heart disease（new version 2010）;Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology（ESC）;Association for European Paediatric Cardiology（AEPC）;ESC Committee for Practice Guidelines（CPG）. ESC Guidelines for the management of grown-up congenital heart disease（new version 2010）. Eur Heart J 31:2915-2957, 2010
16) Silversides CK, Marelli A, Beauchesne L, et al:Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease:executive summary. Can J Cardiol 26:143-150, 2010
17) Warnes CA, Williams RG, Bashore TM, et al:ACC/AHA 2008 guidelines for the management of adults with congenital heart disease:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines（Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease）. Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 52:e143-e263, 2008
18) Chowdhury SM, Hijazi ZM, Fahey JT, et al:Speckle-Tracking Echocardiographic Measures of Right Ventricular Function Correlate With Improvement in Exercise Function After Percutaneous Pulmonary Valve Implantation. J Am Soc Echocardiogr 28:1036-1044, 2015
19) Georgiev S, Ewert P, Eicken A, et al:Munich Comparative Study:Prospective Long-Term Outcome of the Transcatheter Melody Valve Versus Surgical Pulmonary Bioprosthesis With Up to 12 Years of Follow-Up. Circ Cardiovasc Interv 13:e008963, 2020
20) Caughron H, Kim D, Kamioka N, et al:Repeat Pulmonary Valve Replacement:Similar Intermediate-Term Outcomes With Surgical and Transcatheter Procedures. JACC Cardiovasc Interv 11:2495-2503, 2018
21) Rubio V L-LR:Treatment of pulmonary valvular stenosis and tricuspid stenosis using a modified catheter. Second World Congress of Cardiology. Program Abstract II:205, 1954
22) Peterson C, Schilthuis JJ, Dodge-Khatami A, et al:Comparative long-term results of surgery versus balloon valvuloplasty for pulmonary valve stenosis in infants and children. Ann Thorac Surg 764:1078-1082;discussion 1082-1073, 2003
23) Bonhoeffer P, Boudjemline Y, Saliba Z, et al:Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet 3569239:1403-1405, 2000
24) Capodanno D, Petronio AS, Prendergast B, et al:Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves:a consensus statement from the European Association of Percutaneous Cardiovascular Interventions（EAPCI）endorsed by the European Society of Cardiology（ESC）and the European Association for Cardio-Thoracic Surgery（EACTS）. Eur Heart J 38:3382-3390, 2017
25) Søndergaard L, Ihlemann N, Capodanno D, et al:Durability of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients at Lower Surgical Risk. J Am Coll Cardiol 73:546-553, 2019
26) Eicken A, Ewert P, Hager A, et al:Percutaneous pulmonary valve implantation:two-centre experience with more than 100 patients. Eur Heart J 32:1260-1265, 2011
27) Armstrong AK, Balzer DT, Cabalka AK, et al:One-year follow-up of the Melody transcatheter pulmonary valve multicenter post-approval study. JACC Cardiovasc Interv 7:1254-1262, 2014
28) Cheatham JP, Hellenbrand WE, Zahn EM, et al:Clinical and hemodynamic outcomes up to 7 years after transcatheter pulmonary valve replacement in the US melody valve investigational device exemption trial. Circulation 131:1960-1970, 2015
29) Zahn EM, Hellenbrand WE, Lock JE, et al:Implantation of the melody transcatheter pulmonary valve in patients with a dysfunctional right ventricular outflow tract conduit early results from the u.s. Clinical trial. J Am Coll Cardiol 5418:1722-1729, 2009
30) Cabalka AK, Hellenbrand WE, Eicken A, et al:Relationships Among Conduit Type, Pre-Stenting, and Outcomes in Patients Undergoing Transcatheter Pulmonary Valve Replacement in the Prospective North American and European Melody Valve Trials. JACC Cardiovasc Interv 10:1746-1759, 2017. doi:10.1016/j.jcin.2017.05.022. Epub 2017 Aug 16
31) Cardoso R, Ansari M, Garcia D, et al:Prestenting for prevention of melody valve stent fractures:A systematic review and meta-analysis. Catheter Cardiovasc Interv 87:534-539, 2016
32) Kenny D, Rhodes JF, Fleming GA, et al:3-Year Outcomes of the Edwards SAPIEN Transcatheter Heart Valve for Conduit Failure in the Pulmonary Position From the COMPASSION Multicenter Clinical Trial. JACC Cardiovasc Interv 11:1920-1929, 2018
33) Plessis J, Hascoët S, Baruteau A, et al:Edwards SAPIEN Transcatheter Pulmonary Valve Implantation:Results From a French Registry. JACC Cardiovasc Interv 11:1909-1916, 2018
34) Bergersen L, Benson LN, Gillespie MJ, et al:Harmony Feasibility Trial:Acute and Short-Term Outcomes With a Self-Expanding Transcatheter Pulmonary Valve. JACC Cardiovasc Interv 10:1763-1773, 2017
35) Schievano S, Capelli C, Young C, et al:Four-dimensional computed tomography:a method of assessing right ventricular outflow tract and pulmonary artery deformations throughout the cardiac cycle. Eur Radiol 21:36-45, 2011
:A new self-expanding device designed to remodel the right ventricular outflow tract. Catheter Cardiovasc Interv 91:1125-1129, 2018
37) McElhinney DB, Cheatham JP, Jones TK, et al:Stent fracture, valve dysfunction, and right ventricular outflow tract reintervention after transcatheter pulmonary valve implantation:patient-related and procedural risk factors in the US Melody Valve Trial. Circ Cardiovasc Interv 4:602-614, 2011
38) Shahanavaz S, Qureshi AM, Levi DS, et al:Transcatheter Pulmonary Valve Replacement With the Melody Valve in Small Diameter Expandable Right Ventricular Outflow Tract Conduits. JACC Cardiovasc Interv 11:554-564, 2018
39) Sinha S, Aboulhosn J, Asnes J, et al:Initial results from the off-label use of the SAPIEN S3 valve for percutaneous transcatheter pulmonary valve replacement:A multi-institutional experience. Catheter Cardiovasc Interv 93:455-463, 2019
40) Nordmeyer J, Khambadkone S, Coats L, et al:Risk stratification, systematic classification, and anticipatory management strategies for stent fracture after percutaneous pulmonary valve implantation. Circulation 115:1392-1397, 2007
41) Boshoff DE, Cools BL, Heying R, et al:Off-label use of percutaneous pulmonary valved stents in the right ventricular outflow tract:time to rewrite the label? Catheter Cardiovasc Interv 81:987-995, 2013
42) McElhinney DB, Benson LN, Eicken A, et al:Infective endocarditis after transcatheter pulmonary valve replacement using the Melody valve:combined results of 3 prospective North American and European studies. Circ Cardiovasc Interv 6:292-300, 2013
43) Sharma A, Cote AT, Hosking MCK, et al:A Systematic Review of Infective Endocarditis in Patients With Bovine Jugular Vein Valves Compared With Other Valve Types. JACC Cardiovasc Interv 10:1449-1458, 2017
44) Hascoet S, Mauri L, Claude C, et al:Infective Endocarditis Risk After Percutaneous Pulmonary Valve Implantation With the Melody and Sapien Valves. JACC Cardiovasc Interv 10:510-517, 2017
45) McElhinney DB, Sondergaard L, Armstrong AK, et al:Endocarditis After Transcatheter Pulmonary Valve Replacement. J Am Coll Cardiol 72:2717-2728, 2018
46) Bratzler DW, Dellinger EP, Olsen KM, et al:Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm 70:195-283, 2013
47) Alkashkari W, Alsubei A, Hijazi ZM:Transcatheter Pulmonary Valve Replacement:Current State of Art. Curr Cardiol Rep 20:27, 2018
48) Riahi M, Blanke P, Webb J, et al:Early leaflet thrombosis complicating transcatheter implantation of a Sapien 3 valve in a native right ventricular outflow tract. Catheter Cardiovasc Interv 92:925-929, 2018
49) Makkar RR, Fontana G, Jilaihawi H, et al:Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves. N Engl J Med 373:2015-2024, 2015
50) Hansson NC, Grove EL, Andersen HR, et al:Transcatheter Aortic Valve Thrombosis:Incidence, Predisposing Factors, and Clinical Implications. J Am Coll Cardiol 68:2059-2069, 2016
51) Watanabe H, Domei T, Morimoto T, et al:Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI:The STOPDAPT-2 Randomized Clinical Trial. JAMA 321:2414-2427, 2019
52) Egbe AC, Pislaru SV, Pellikka PA, et al:Bioprosthetic Valve Thrombosis Versus Structural Failure:Clinical and Echocardiographic Predictors. J Am Coll Cardiol 66:2285-2294, 2015
53) Egbe AC, Connolly HM, Miranda WR, et al:Outcomes of Bioprosthetic Valves in the Pulmonary Position in Adults with Congenital Heart Disease. Ann Thorac Surg 108:1410-1415, 2019
掲載誌情報
